VR Logo

Femasys Inc. (FEMY) download report


Healthcare | Medical Devices & Equipment

Femasys Inc. (FEMY) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec.

IPO Date: 18-Jun-2021

Founder, Chairman, CEO & Pres: Ms. Kathy Lee-Sepsick

SVP of Operations & Sec.: Mr. Daniel Scott Currie

Listing: NASDAQ: FEMY

Country: United States

Headquarters: Suwanee, GA

Website: https://www.femasys.com

Key Facts

Market cap: $22.21 Mln

Revenue (TTM): $0.60 Mln

Earnings (TTM): $-8.59 Mln

Cash: $21.77 Mln

Total Debt: $0.75 Mln

Insider's Holding: 19.01%

Liquidity: Low

52 Week range: $1.26 - 10.79

Shares outstanding: 11,813,600

Stock Performance

Time Period Femasys (FEMY) S&P BSE Sensex S&P Small-Cap 600
YTD-45.77-8.74-16.95
1 month32.19-2.01-4.64
3 months-4.73-7.32-12.54
1 Year-75.260.45-16.18
3 Years--10.328.06
5 Years--11.296.38
10 Years--12.1410.57
As on 27-Jun-2022